OptimizeRx Corp 10-Q

Item 5. Other Information None Item 6. Exhibits Exhibit Number Description of Exhibit 10.1** Addendum to the employment agreement between William Febbo and the Company dated September 24, 2020 31.1** Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 31.2** Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 32.1** Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 101.INS Inline XBRL Instance Document. 101.SCH Inline XBRL Taxonomy Extension Schema Document. 101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document. 101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document. 101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document. 101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document. 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). ** Provided herewith 20 SIGNATURES In accordance with the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. OptimizeRx Corporation Date: August 4, 2021 By: /s/ William J. Febbo William J. Febbo Title: Chief Executive Officer, Principal Executive Officer, and Director OptimizeRx Corporation Date: August 4, 2021 By: /s/ Douglas P. Baker Douglas P. Baker Title: Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer 21